Recurring mutations in isocitrate dehydrogenase (IDH) genes are detected in approximately 20% of adult patients with AML, commonly at codon R132 in IDH1 and R140 or R172 in IDH2 [3, 4]. Here, IDH2 is linked to acute myeloid leukemia.